: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription

Articles published in Respir Med
Retrieve available abstracts of 371 articles:
HTML format

Single Articles

April 2024

ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
PubMed Abstract available

SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
PubMed Abstract available

FARKAS A, Horvath A, Reti I, Ilyes N, et al
Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
Respir Med. 2024;224:107576.
PubMed Abstract available

MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
Respir Med. 2024;224:107564.
PubMed Abstract available

MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
Predicting exacerbations in COPD in the Danish general population.
Respir Med. 2024;224:107557.
PubMed Abstract available

BROCKWAY K, Ahmed S
Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
Respir Med. 2024;224:107553.
PubMed Abstract available

LAI K, Sun D, Dai R, Samoro R, et al
Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
PubMed Abstract available

GOTO T, Banno M, Kimura R
Revisiting the use of high flow nasal cannula in acute exacerbation of COPD and conclusion of trial.
Respir Med. 2024;225:107602.
PubMed

LORENZANA I, Galera R, Casitas R, Martinez-Ceron E, et al
Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients.
Respir Med. 2024;225:107597.
PubMed Abstract available

XU X, Yin J, Yang Y, Liu H, et al
Advances in co-pathogenesis of the united airway diseases.
Respir Med. 2024;225:107580.
PubMed Abstract available

STEGER M, Canuet M, Enache I, Goetsch T, et al
Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
Respir Med. 2024;225:107585.
PubMed Abstract available

BELL K, Lawson J, Penz E, Cammer A, et al
Systematic review of tailored dietary advice and dietitian involvement in the treatment of chronic obstructive pulmonary disease (COPD).
Respir Med. 2024;225:107584.
PubMed Abstract available

VERWEEL L, Packham T, Goldstein R, Brooks D, et al
Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
Respir Med. 2024;225:107588.
PubMed Abstract available

LUO L, Tang J, Du X, Li N, et al
Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
Respir Med. 2024;225:107586.
PubMed Abstract available

March 2024

YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
PubMed Abstract available

JEONG J, Nam YH, Sim DW, Kim BK, et al
Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
Respir Med. 2024;225:107598.
PubMed Abstract available

WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
PubMed Abstract available

NIERI D, Morani C, De Francesco M, Gaeta R, et al
Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.
Respir Med. 2024;223:107563.
PubMed Abstract available

LAI Y, Cavalheri V, Sawyer A, Hill K, et al
Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis.
Respir Med. 2024;223:107554.
PubMed Abstract available

LAU F, Schupp T, Schmitt A, Reinhardt M, et al
Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
Respir Med. 2024;223:107536.
PubMed Abstract available

February 2024

MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
Impact of biologics on lung hyperinflation in patients with severe asthma.
Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
PubMed Abstract available

ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
PubMed Abstract available

POSTHUMA R, van der Molen MC, Hartman JE, Spruit MA, et al
Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves.
Respir Med. 2024 Feb 17:107558. doi: 10.1016/j.rmed.2024.107558.
PubMed Abstract available

HOGARTH DK, Delage A, Zgoda MA, Nsiah-Dosu S, et al
Efficacy and safety of the spiration valve System for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE).
Respir Med. 2024;224:107565.
PubMed Abstract available

ROTT C, Limen E, Kriegsmann K, Herth F, et al
Analysis of body composition with bioelectrical impedance analysis in patients with severe COPD and pulmonary emphysema.
Respir Med. 2024 Feb 11:107559. doi: 10.1016/j.rmed.2024.107559.
PubMed Abstract available

FARZANDIPOUR M, Arani MH, Sharif R, Nabovati E, et al
Improving asthma control and quality of life via a smartphone self-management app: A randomized controlled trial.
Respir Med. 2024 Feb 5:107539. doi: 10.1016/j.rmed.2024.107539.
PubMed Abstract available

WU F, Dai C, Zhou Y, Deng Z, et al
Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease: A post hoc analysis of the Tie-COPD study.
Respir Med. 2024;222:107527.
PubMed Abstract available

KO FWS, Xu X, Chau C, Navarro A, et al
Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong.
Respir Med. 2024;222:107516.
PubMed Abstract available

JAMES BD, Greening NJ, Tracey N, Haldar P, et al
Prognostication of co-morbidity clusters on hospitalisation and mortality in advanced COPD.
Respir Med. 2024;222:107525.
PubMed Abstract available

OVENHOLM H, Zaigham S, Frantz S, Nihlen U, et al
Inhomogeneity of ventilation in smokers and mild COPD assessed by the ratio of alveolar volume to total lung capacity.
Respir Med. 2024;222:107524.
PubMed Abstract available

ALVAREZ-DOBANO JM, Rodriguez-Garcia C, Atienza G, Toubes ME, et al
Analysis of the quality of e-Consultations in chronic obstructive pulmonary disease.
Respir Med. 2024;222:107514.
PubMed Abstract available

ZHANG Y, Peng J, Liu L, Cui H, et al
Prevalence, characteristics and significant predictors for cardiovascular disease of patients with preserved ratio impaired spirometry: A 10-year prospective cohort study in China.
Respir Med. 2024;222:107523.
PubMed Abstract available

WANG J, Feng F, Zhao Y, Bai L, et al
Dietary nitrate supplementation to enhance exercise capacity in patients with COPD: Evidence from a meta-analysis of randomized controlled trials and a network pharmacological analysis.
Respir Med. 2024;222:107498.
PubMed Abstract available

VOGELMEIER CF, Friedrich FW, Timpel P, Kossack N, et al
Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study.
Respir Med. 2024;222:107506.
PubMed Abstract available

COMETA M, Ursitti A, Lombardo LP, Rana R, et al
Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
Respir Med. 2024;222:107509.
PubMed Abstract available

QAISAR R, Karim A, Muhammad T, Ahmad F, et al
Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease.
Respir Med. 2024;222:107510.
PubMed Abstract available

LIU H, Xie Y, Huang Y, Luo K, et al
The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Respir Med. 2024;222:107501.
PubMed Abstract available

January 2024

BASAVARAJ A, Choate R, Becker BC, Aksamit TR, et al
Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry.
Respir Med. 2024 Jan 31:107555. doi: 10.1016/j.rmed.2024.107555.
PubMed Abstract available

ZHANG T, Xu L, Zhang Y, Zhen L, et al
The diagnostic value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in children with chest tightness-variant asthma (CTVA).
Respir Med. 2024 Jan 27:107543. doi: 10.1016/j.rmed.2024.107543.
PubMed Abstract available

PAPI A, Castro M, Corren J, Pavord ID, et al
Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
PubMed Abstract available

CHASE NM, Littlejohn M, Holweg CTJ, Millette LA, et al
Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
Respir Med. 2024 Jan 20:107537. doi: 10.1016/j.rmed.2024.107537.
PubMed Abstract available

SIORA A, Vontetsianos A, Chynkiamis N, Anagnostopoulou C, et al
Small airways in asthma: From inflammation and pathophysiology to treatment response.
Respir Med. 2024 Jan 14:107532. doi: 10.1016/j.rmed.2024.107532.
PubMed Abstract available

BACKMAN H, Lindmark SW, Hedman L, Kankaanranta H, et al
The interplay between obesity and blood neutrophils in adult-onset asthma.
Respir Med. 2024 Jan 10:107529. doi: 10.1016/j.rmed.2024.107529.
PubMed

BRESLAVSKY A, Al Qaied A, Tsenter P, Mukaseev N, et al
Comparison of clinical remission criteria for severe asthma patients receiving biologic therapy.
Respir Med. 2024 Jan 8:107528. doi: 10.1016/j.rmed.2024.107528.
PubMed Abstract available

NORWEG A, Hofferber B, Maguire S, Oh C, et al
Breathing on the mind: Treating dyspnea and anxiety symptoms with biofeedback in chronic lung disease - A qualitative analysis.
Respir Med. 2024;221:107505.
PubMed Abstract available

MIRAVITLLES M, Criner GJ, Mall MA, Rowe SM, et al
Potential systemic effects of acquired CFTR dysfunction in COPD.
Respir Med. 2024;221:107499.
PubMed Abstract available

DELMAS MC, Pasquereau A, Renuy A, Benezet L, et al
Electronic cigarette use and respiratory symptoms in the French population-based Constances cohort.
Respir Med. 2024;221:107496.
PubMed Abstract available

HUANG X, Gu H, Wu R, Chen L, et al
Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes.
Respir Med. 2024;221:107480.
PubMed Abstract available

SANTOS EAD, Pinto TF, Xavier RF, Stelmach R, et al
Elastic tape reduces dyspnea and improves health status in the short term in nonobese COPD males: A randomized controlled trial.
Respir Med. 2024;221:107459.
PubMed Abstract available

December 2023

VISSER E, Ten Brinke A, Sizoo D, Pepels JJS, et al
Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review.
Respir Med. 2023;221:107504.
PubMed Abstract available

DE-MIGUEL-DIEZ J, Gutierrez-Albaladejo N, Caballero-Segura FJ, Lopez-de-Andres A, et al
Trends and sex differences in atrial fibrillation among patients hospitalized due to asthma: Insights from a nationwide population-based discharge database in Spain, 2016-2021.
Respir Med. 2023;221:107508.
PubMed Abstract available

WATSON KE, Lee AL, Dwyer TJ, McKeough ZJ, et al
Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments implemented by allied health professionals and nurses.
Respir Med. 2023 Dec 21:107503. doi: 10.1016/j.rmed.2023.107503.
PubMed Abstract available

MIR FAKHRAEI R, Lindberg E, Benediktsdottir B, Svanes C, et al
Gastroesophageal reflux and snoring are related to asthma and respiratory symptoms: Results from a Nordic longitudinal population survey.
Respir Med. 2023 Dec 13:107495. doi: 10.1016/j.rmed.2023.107495.
PubMed Abstract available

RITCHEY KC, Yohannes AM, Locke ER, Chen S, et al
Association between self-reported falling risk and risk of hospitalization for patients with chronic obstructive pulmonary disease.
Respir Med. 2023;220:107466.
PubMed Abstract available

XIA J, Yang H, Zhan Q, Fan Y, et al
High-flow nasal cannula may prolong the length of hospital stay in patients with hypercapnic acute COPD exacerbation.
Respir Med. 2023;220:107465.
PubMed Abstract available

SUN Y, Jiang F, Li R, Xiao L, et al
The future landscape of immunology in COPD: A bibliometric analysis.
Respir Med. 2023;220:107462.
PubMed Abstract available

LLAMAS-SAEZ C, Saez-Vaquero T, Jimenez-Garcia R, Lopez-de-Andres A, et al
Physical activity among adults with chronic obstructive pulmonary disease in Spain (2014-2020): Temporal trends, sex differences, and associated factors.
Respir Med. 2023;220:107458.
PubMed Abstract available

CHAIWONG W, Deesomchok A, Pothirat C, Duangjit P, et al
Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.
Respir Med. 2023;220:107460.
PubMed Abstract available

VIANA SMDNR, de Bruin VMS, Vasconcelos RS, Nogueira ANC, et al
Melatonin supplementation enhances pulmonary rehabilitation outcomes in COPD: a randomized, double-blind, placebo-controlled study.
Respir Med. 2023;220:107441.
PubMed Abstract available

ANANDAN J, Dwivedi DP, Govindaraj V
Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study.
Respir Med. 2023;220:107452.
PubMed Abstract available

SUN Y, Zhang Y, Bai W, Liu X, et al
Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.
Respir Med. 2023;220:107451.
PubMed Abstract available

QUADFLIEG K, Machado A, de Lima FF, Dederen A, et al
Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
Respir Med. 2023;220:107437.
PubMed Abstract available

TSUI AYY, Chau RMW, Cheing GLY, Mok TYW, et al
Effect of chest wall mobilization on respiratory muscle function in patients with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial.
Respir Med. 2023;220:107436.
PubMed Abstract available

November 2023

FREELS L, Herman A, Lukas S, Chan AHY, et al
Asthma control and associated risk factors among adults with current asthma: Findings from 2019 behavioral risk factor surveillance system asthma call-back survey.
Respir Med. 2023 Nov 25:107479. doi: 10.1016/j.rmed.2023.107479.
PubMed Abstract available

ROCHE N, Yorgancioglu A, Cruz AA, Garcia G, et al
Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting beta(2)-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance a
Respir Med. 2023 Nov 24:107478. doi: 10.1016/j.rmed.2023.107478.
PubMed Abstract available

MATTILA T, Vasankari T, Herse F, Leskela RL, et al
Contrasting healthcare costs of COPD and asthma in elderly.
Respir Med. 2023 Nov 21:107477. doi: 10.1016/j.rmed.2023.107477.
PubMed Abstract available

URDOVA V, Rogers L, Jesenak M, Seys SF, et al
Real-life studies and registries of severe asthma: The advent of digital technology.
Respir Med. 2023 Nov 3:107429. doi: 10.1016/j.rmed.2023.107429.
PubMed

EPELBAUM O, Gemoets DE
Good COP or bad COP: How much steroid is enough to avoid relapse?
Respir Med. 2023;218:107413.
PubMed

LIM JU, Park S, Yoon JH, Lee SE, et al
Efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation.
Respir Med. 2023;218:107410.
PubMed Abstract available

KIM YS, Hwang YI, Lee JH, Park YB, et al
Clinical significance of normalized airflow obstruction in patients with chronic obstructive pulmonary disease.
Respir Med. 2023;218:107398.
PubMed Abstract available

MEHTA GD, Arroyo AC, Zhu Z, Espinola JA, et al
Association between severe bronchiolitis in infancy and age 6-year lung function.
Respir Med. 2023;218:107401.
PubMed Abstract available

SUN Y, Molins E, Daoud SZ, Trivedi R, et al
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study.
Respir Med. 2023;218:107393.
PubMed Abstract available

WILDE LJ, Percy C, Clark C, Ward G, et al
Views and experiences of healthcare practitioners supporting people with COPD who have used activity monitors: "More than just steps".
Respir Med. 2023;218:107395.
PubMed Abstract available

ATSUMI K, Hisakane K, Mikami E, Suzuki T, et al
Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia.
Respir Med. 2023;218:107390.
PubMed Abstract available

CHERIAN M, Adam V, Ross B, Bourbeau J, et al
Mortality in individuals with COPD on long-term home non-invasive ventilation.
Respir Med. 2023;218:107378.
PubMed Abstract available

BRUSSELLE G, Himpe U, Fievez P, Leys M, et al
Evolving to a single inhaler extrafine LABA/LAMA/ICS - Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE).
Respir Med. 2023;218:107368.
PubMed Abstract available

ICHIKAWA T, Tajiri S, Yokoba M, Horimizu Y, et al
Sniff and reverse-sniff nasal respiratory pressures after exacerbation of chronic obstructive pulmonary disease: A single-center prospective study.
Respir Med. 2023;219:107438.
PubMed Abstract available

MATERA MG, Rinaldi B, Ambrosio C, Cazzola M, et al
Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
Respir Med. 2023;219:107439.
PubMed Abstract available

QU Y, Gong Y, Li L, Song Y, et al
Atomization efficacy of a novel micro-dose mesh nebulizer (CVS-100) versus the traditional mesh nebulizer (M102) in adults with chronic obstructive pulmonary disease: A randomized non-inferiority clinical trial.
Respir Med. 2023;219:107434.
PubMed Abstract available

MENESES-ECHAVEZ JF, Chavez Guapo N, Loaiza-Betancur AF, Machado A, et al
Pulmonary rehabilitation for acute exacerbations of COPD: A systematic review.
Respir Med. 2023;219:107425.
PubMed Abstract available

BLONDEEL A, Hermans F, Breuls S, Wuyts M, et al
Factors associated to physical activity in patients with COPD: An ecological approach.
Respir Med. 2023;219:107424.
PubMed Abstract available

CESTELLI L, Gulsvik A, Johannessen A, Stavem K, et al
Reduced lung function and cause-specific mortality: A population-based study of Norwegian men followed for 26 years.
Respir Med. 2023;219:107421.
PubMed Abstract available

DE VOS R, Hicks A, Lomax M, Mackenzie H, et al
A systematic review of methods of scoring inhaler technique.
Respir Med. 2023;219:107430.
PubMed Abstract available

PITRE T, Abbasi S, Su J, Mah J, et al
Home high flow nasal cannula for chronic hypercapnic respiratory failure in COPD: A systematic review and meta-analysis.
Respir Med. 2023;219:107420.
PubMed Abstract available

OTSUKA J, Yoshizawa S, Kudo K, Osoreda H, et al
Clinical features of relapsed connective tissue disease-associated organizing pneumonia.
Respir Med. 2023;219:107419.
PubMed Abstract available

October 2023

RENNER A, Stoshikj S, Pohl W, Bal C, et al
Characterization of Austrian severe asthma patients.
Respir Med. 2023 Oct 10:107427. doi: 10.1016/j.rmed.2023.107427.
PubMed Abstract available

HENRY C, Biardel S, Boucher M, Godbout K, et al
Bronchial thermoplasty attenuates bronchodilator responsiveness.
Respir Med. 2023;217:107340.
PubMed Abstract available

AXELSSON M, Backman H, Nwaru BI, Stridsman C, et al
Underdiagnosis and misclassification of COPD in Sweden - A Nordic Epilung study.
Respir Med. 2023;217:107347.
PubMed Abstract available

PEREZ T, Roche N, Nunes H, Burgel PR, et al
Dyspnea-induced Limitation (DYSLIM), a new self-administered concise questionnaire to evaluate dyspnea-related activity limitation in chronic respiratory diseases.
Respir Med. 2023;217:107309.
PubMed Abstract available

SHIMADA T, Chubachi S, Otake S, Sakurai K, et al
Differential impacts between fat mass index and fat-free mass index on patients with COPD.
Respir Med. 2023;217:107346.
PubMed Abstract available

September 2023

ROGERS L, Jesenak M, Bjermer L, Hanania NA, et al
Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
Respir Med. 2023 Sep 28:107414. doi: 10.1016/j.rmed.2023.107414.
PubMed Abstract available

ITO M, Furuuchi K, Fujiwara K, Watanabe F, et al
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.
Respir Med. 2023;219:107417.
PubMed Abstract available

WINSA-LINDMARK S, Stridsman C, Sahlin A, Hedman L, et al
Severity of adult onset-asthma-a matter of blood neutrophils and severe obesity.
Respir Med. 2023 Sep 26:107418. doi: 10.1016/j.rmed.2023.107418.
PubMed Abstract available

KROES JA, Van Hal LHG, Van Dijk L, Zielhuis SW, et al
The perceived waning of biologics in severe asthma.
Respir Med. 2023 Sep 25:107416. doi: 10.1016/j.rmed.2023.107416.
PubMed Abstract available

KLINGER JR, Wu B, Morland K, Classi P, et al
Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
Respir Med. 2023 Sep 18:107412. doi: 10.1016/j.rmed.2023.107412.
PubMed Abstract available

BROCK JM, Bohmker F, Schuster PU, Eberhardt R, et al
Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patients.
Respir Med. 2023 Sep 4:107399. doi: 10.1016/j.rmed.2023.107399.
PubMed Abstract available

VAARST JK, Sperling S, Dahl VN, Floe A, et al
Lung abscess: Clinical characteristics of 222 Danish patients diagnosed from 2016 to 2021.
Respir Med. 2023;216:107305.
PubMed Abstract available

PELLEGRINO D, Casas-Recasens S, Faner R, Palange P, et al
When GETomics meets aging and exercise in COPD.
Respir Med. 2023;216:107294.
PubMed Abstract available

BJORKLUND F, Palm A, Gorani JA, Ahmadi Z, et al
Breathlessness and exercise performance to predict mortality in long-term oxygen therapy - The population-based DISCOVERY study.
Respir Med. 2023;216:107306.
PubMed Abstract available

August 2023

MASPERO JF, Shafazand S, Cole J, Pavord ID, et al
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
Respir Med. 2023 Aug 31:107344. doi: 10.1016/j.rmed.2023.107344.
PubMed Abstract available

COTTINI M, Bondi B, Bagnasco D, Braido F, et al
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control.
Respir Med. 2023 Aug 16:107391. doi: 10.1016/j.rmed.2023.107391.
PubMed Abstract available

ASSAF S, Stenberg H, Jesenak M, Tarasevych SP, et al
Asthma in the era of COVID-19.
Respir Med. 2023 Aug 9:107373. doi: 10.1016/j.rmed.2023.107373.
PubMed Abstract available

DIERICK BJH, Achterbosch M, Eikholt AA, Been-Buck S, et al
Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial.
Respir Med. 2023 Aug 5:107376. doi: 10.1016/j.rmed.2023.107376.
PubMed Abstract available

RODRIGUEZ GARCIA C, Ruano-Ravina A, Perez Rios M, Martin Gisbert L, et al
Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review.
Respir Med. 2023;214:107284.
PubMed Abstract available

CAZZOLA M, Blasi F
There is still no established and accepted definition of COPD.
Respir Med. 2023;214:107262.
PubMed

D'ANNA SE, Dossena F, Gnemmi I, Brun P, et al
Bacterial load and related innate immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
Respir Med. 2023;215:107297.
PubMed Abstract available

QAISAR R, Karim A, Muhammad T, Alkahtani SA, et al
Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications.
Respir Med. 2023;215:107298.
PubMed Abstract available

VAN DER MOLEN MC, Slebos DJ, Augustijn SWS, Kerstjens HAM, et al
The minimal important difference of the constant work rate cycle test in severe COPD.
Respir Med. 2023;215:107265.
PubMed Abstract available

KAMINSKY DA, He J, Henderson R, Dixon AE, et al
Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma.
Respir Med. 2023 Aug 1:107375. doi: 10.1016/j.rmed.2023.107375.
PubMed Abstract available

July 2023

YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting beta(2)-agonist plus short-acting beta(2) agonist reliever or maintenance and reliever therapy for asthma.
Respir Med. 2023 Jul 29:107377. doi: 10.1016/j.rmed.2023.107377.
PubMed Abstract available

DIAMANT Z, Jesenak M, Hanania NA, Heaney LG, et al
EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.
Respir Med. 2023 Jul 28:107361. doi: 10.1016/j.rmed.2023.107361.
PubMed

JESENAK M, Durdik P, Oppova D, Franova S, et al
Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic.
Respir Med. 2023 Jul 27:107372. doi: 10.1016/j.rmed.2023.107372.
PubMed Abstract available

CHAN AHY, Tomlin A, Beyene K, Harrison J, et al
Asthma exacerbations in New Zealand 2010-2019: A national population-based study.
Respir Med. 2023;217:107365.
PubMed Abstract available

PONTE EV, Rocha DGD, Guinossi RM, Bertoche L, et al
Evaluating the relationship between the type of rescue medication and the adequacy of asthma maintenance therapy.
Respir Med. 2023 Jul 18:107364. doi: 10.1016/j.rmed.2023.107364.
PubMed Abstract available

DIAMANT Z, Seys SF, Rogers L, Hanania NA, et al
Integrating innovations in asthma research into clinical practice.
Respir Med. 2023;217:107345.
PubMed

BAYDUR A, Barbers R, May D
Effect of bronchial thermoplasty on static and dynamic lung compliance and resistance in patients with severe persistent asthma.
Respir Med. 2023 Jul 8:107341. doi: 10.1016/j.rmed.2023.107341.
PubMed Abstract available

GEPHINE S, Fry S, Margoline E, Gicquello A, et al
Home-based pulmonary rehabilitation for adults with severe asthma exposed to psychosocial chronic stressors.
Respir Med. 2023 Jul 7:107349. doi: 10.1016/j.rmed.2023.107349.
PubMed Abstract available

PORTACCI A, Iorillo I, Quaranta VN, Maselli L, et al
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.
Respir Med. 2023;217:107348.
PubMed Abstract available

BAKHT MUHAMMAD
Comment on: Identifying responders and exploring mechanisms of action of the endobronchial coil treatment for emphysema.
Respir Med. 2023 Jul 1:107343. doi: 10.1016/j.rmed.2023.107343.
PubMed

June 2023

KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
Respir Med. 2023 Jun 29:107334. doi: 10.1016/j.rmed.2023.107334.
PubMed Abstract available

VAKHSHOORZADEH J, Lui JK, Sangani RA, Trojanowski MA, et al
Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.
Respir Med. 2023;216:107333.
PubMed

MOHAN A, Lugogo NL
Mild asthma: Lessons learned and remaining questions.
Respir Med. 2023 Jun 14:107326. doi: 10.1016/j.rmed.2023.107326.
PubMed Abstract available

ADRISH M, Akuthota P
Approach to non-type 2 asthma.
Respir Med. 2023 Jun 10:107327. doi: 10.1016/j.rmed.2023.107327.
PubMed

NISHIYAMA H, Kanemitsu Y, Hara J, Fukumitsu K, et al
Bronchial thermoplasty improves cough hypersensitivity and cough in severe asthmatics.
Respir Med. 2023 Jun 10:107303. doi: 10.1016/j.rmed.2023.107303.
PubMed Abstract available

PANETTIERI RA, Lugogo N, Moore WC, Chipps BE, et al
Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
Respir Med. 2023 Jun 6:107285. doi: 10.1016/j.rmed.2023.107285.
PubMed Abstract available

STURESSON A, Hedman L, Stridsman C, Lindberg A, et al
Obesity associates with increased all-cause and cardiovascular mortality in adults with asthma.
Respir Med. 2023 Jun 4:107301. doi: 10.1016/j.rmed.2023.107301.
PubMed Abstract available

SELBERG S, Karlsson Sundbaum J, Konradsen JR, Backman H, et al
Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
Respir Med. 2023;216:107308.
PubMed Abstract available

KISIEL MA, Sedvall M, Malinovschi A, Franklin KA, et al
Inflammatory bowel disease and asthma. Results from the RHINE study.
Respir Med. 2023 Jun 2:107307. doi: 10.1016/j.rmed.2023.107307.
PubMed Abstract available

PETERSSON SJOGREN M, Karedal M, Broberg K, Assarsson E, et al
Sensitive methods for assessment of lung health in welders and controls.
Respir Med. 2023;212:107244.
PubMed Abstract available

ESTEBAN C, Anton-Ladislao A, Aramburu A, Chasco L, et al
Change in physical activity related to admission for exacerbation in COPD patients.
Respir Med. 2023;212:107236.
PubMed Abstract available

AARHUS L, Sand M, Engdahl B
COPD and 20-year hearing decline: The HUNT cohort study.
Respir Med. 2023;212:107221.
PubMed Abstract available

ASAI N, Ohkuni Y, Ohashi W, Kaneko N, et al
Modified MRC assessment and FEV1.0 can predict frequent acute exacerbation of COPD: An observational prospective cohort study at a single-center in Japan.
Respir Med. 2023;212:107218.
PubMed Abstract available

PORPODIS K, Bartziokas K, Chatziapostolou P, Korkontzelou A, et al
"Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study - The TRIBUNE study".
Respir Med. 2023;212:107219.
PubMed Abstract available

DE MIGUEL-DIEZ J, Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V, et al
Trends in prevalence and the effects on hospital outcomes of dementia in patients hospitalized with acute COPD exacerbation.
Respir Med. 2023;212:107223.
PubMed Abstract available

May 2023

BRUNN B, Hapfelmeier A, Jorres RA, Schultz K, et al
Development of a diagnostic score using FeNO and symptoms to predict asthma.
Respir Med. 2023 May 29:107299. doi: 10.1016/j.rmed.2023.107299.
PubMed Abstract available

LIANG Y, Zhang J, Bai S, Du S, et al
Short-term and long-term effects of cesarean section on asthma and wheezing: A cohort study and meta-analysis.
Respir Med. 2023 May 29:107300. doi: 10.1016/j.rmed.2023.107300.
PubMed Abstract available

FONG KY, Zhao JJ, Syn NL, Nair P, et al
Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
Respir Med. 2023 May 29:107302. doi: 10.1016/j.rmed.2023.107302.
PubMed Abstract available

LOZANO-ESPINOSA M, Antolin-Amerigo D, Riera J, Gordo Vidal F, et al
Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review.
Respir Med. 2023;215:107246.
PubMed Abstract available

KHAN S, Ouaalaya EH, Chauveau AD, Scherer E, et al
Whispers of change in preschool asthma phenotypes: Findings in the French ELFE cohort.
Respir Med. 2023 May 22:107263. doi: 10.1016/j.rmed.2023.107263.
PubMed Abstract available

BOUSSO A, Chuffart C, Leroy M, Gicquello A, et al
Severity and phenotypes of dyspnea in asthma: Impact of comorbidities.
Respir Med. 2023 May 20:107276. doi: 10.1016/j.rmed.2023.107276.
PubMed Abstract available

KHORASANI AM, Mohammadi B, Saghafi MR, Mohammadi S, et al
The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.
Respir Med. 2023 May 3:107260. doi: 10.1016/j.rmed.2023.107260.
PubMed Abstract available

TOUMPANAKIS D, Usmani OS
Small airways disease in patients with alpha-1 antitrypsin deficiency.
Respir Med. 2023;211:107222.
PubMed Abstract available

LAORDEN D, Zamarron E, Romero D, Dominguez-Ortega J, et al
Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
Respir Med. 2023;211:107216.
PubMed

BASHIR MBA, Basna R, Hedman L, Backman H, et al
Interaction of smoking and social status on the risk of respiratory outcomes in a Swedish adult population: A Nordic Epilung study.
Respir Med. 2023;211:107192.
PubMed Abstract available

MORRIS JR, Harrison SL, Robinson J, Martin D, et al
Non-pharmacological and non-invasive interventions for chronic pain in people with chronic obstructive pulmonary disease: A systematic review without meta-analysis.
Respir Med. 2023;211:107191.
PubMed Abstract available

BRAY K, Bodduluri S, Kim YI, Sthanam V, et al
Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease.
Respir Med. 2023;211:107195.
PubMed Abstract available

AN Q, Sandlund M, Agnello D, McCaffrey L, et al
A scoping review of co-creation practice in the development of non-pharmacological interventions for people with Chronic Obstructive Pulmonary Disease: A health CASCADE study.
Respir Med. 2023;211:107193.
PubMed Abstract available

April 2023

PRICE OJ, Simpson AJ
Exercise and asthma - trigger or treatment?
Respir Med. 2023;213:107247.
PubMed Abstract available

ZHU D, Dai H, Zhu H, Fang Y, et al
Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics.
Respir Med. 2023;209:107150.
PubMed Abstract available

GU W, Tian Z, Tian W, Song Y, et al
Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011-2014.
Respir Med. 2023;209:107147.
PubMed Abstract available

ROODENBURG SA, Slebos DJ, van Dijk M, Koster TD, et al
Improved exercise capacity results in a survival benefit after endobronchial valve treatment.
Respir Med. 2023;210:107175.
PubMed Abstract available

FARROKHI M, Ahadiat SA
Stability of distinct symptom experiences in patients with COPD.
Respir Med. 2023;210:107166.
PubMed

March 2023

KISIEL MA, Arnfelt O, Lindberg E, Jogi O, et al
Association between abdominal and general obesity and respiratory symptoms, asthma and COPD. Results from the RHINE study.
Respir Med. 2023;211:107213.
PubMed Abstract available

FLUME PA, Basavaraj A, Garcia B, Winthrop K, et al
Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis.
Respir Med. 2023 Mar 15:107217. doi: 10.1016/j.rmed.2023.107217.
PubMed Abstract available

VAN DER BURG N, Tufvesson E
Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
Respir Med. 2023 Mar 14:107211. doi: 10.1016/j.rmed.2023.107211.
PubMed

VAN ZYL-SMIT RN, Kerstjens HA, Maspero JF, Kostikas K, et al
Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
Respir Med. 2023 Mar 9:107172. doi: 10.1016/j.rmed.2023.107172.
PubMed Abstract available

WANG H, Liu Q, Liu L, Cao J, et al
High-intensity interval training improves the outcomes of patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
Respir Med. 2023;208:107128.
PubMed Abstract available

TRAN TV, Kinney GL, Comellas A, Hoth KF, et al
Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease.
Respir Med. 2023;208:107126.
PubMed Abstract available

TSAI CL, Chang WP, Lin YK, Ho SC, et al
Physical frailty related to cognitive impairment and COPD exacerbation: A cross-sectional study.
Respir Med. 2023;208:107129.
PubMed

DONOHUE JF, Ferguson GT, Ohar JA, Lombardi DA, et al
Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.
Respir Med. 2023;208:107123.
PubMed Abstract available

February 2023

BAKAKOS P, Tryfon S, Palamidas A, Mathioudakis N, et al
Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
Respir Med. 2023;210:107170.
PubMed Abstract available

ERJEFALT JS
Anatomical and histopathological approaches to asthma phenotyping.
Respir Med. 2023 Feb 21:107168. doi: 10.1016/j.rmed.2023.107168.
PubMed Abstract available

MCSHANE PJ, Choate R, Johnson M, Maselli DJ, et al
Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry.
Respir Med. 2023;209:107167.
PubMed Abstract available

COTTINI M, Lombardi C, Comberiati P, Landi M, et al
Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: A perfect storm.
Respir Med. 2023 Feb 14:107154. doi: 10.1016/j.rmed.2023.107154.
PubMed Abstract available

DESORMEAU B, Smyrnova A, Drouin O, Ducharme FM, et al
Oscillometry to support clinical assessment in asthmatic preschoolers: Real-life impact.
Respir Med. 2023 Feb 6:107148. doi: 10.1016/j.rmed.2023.107148.
PubMed Abstract available

SORENSEN KG, Oymar K, Jonsson G, Dalen I, et al
Are BMI and adipokines associated with asthma, atopy and lung function in young adults previously hospitalized for bronchiolitis?
Respir Med. 2023 Feb 6:107149. doi: 10.1016/j.rmed.2023.107149.
PubMed Abstract available

GARCIA-RIO F, Miravitlles M, Soriano JB, Cosio BG, et al
Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach.
Respir Med. 2023;207:107115.
PubMed Abstract available

AGUSTI A, Ambrosino N, Blackstock F, Bourbeau J, et al
COPD: Providing the right treatment for the right patient at the right time.
Respir Med. 2023;207:107041.
PubMed Abstract available

O'HOSKI S, Kuspinar A, Richardson J, Wald J, et al
Responsiveness of the late life disability instrument to pulmonary rehabilitation in people with COPD.
Respir Med. 2023;207:107113.
PubMed Abstract available

HILVERING B, Koenderman L
Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases.
Respir Med. 2023;207:107094.
PubMed Abstract available

January 2023

DIAMANT Z, van Maaren M, Muraro A, Jesenak M, et al
Allergen immunotherapy for allergic asthma - The future seems bright.
Respir Med. 2023 Jan 23:107125. doi: 10.1016/j.rmed.2023.107125.
PubMed

POMPE E, Kwee AK, Tejwani V, Siddharthan T, et al
Imaging-derived biomarkers in Asthma: Current status and future perspectives.
Respir Med. 2023 Jan 23:107130. doi: 10.1016/j.rmed.2023.107130.
PubMed Abstract available

AL-SHUWELI S, Landt E, Ellervik C, Poulsen HE, et al
Risk of asthma in offspring of asthmatic fathers versus mothers: A population-based study of 21,000 individuals in Denmark.
Respir Med. 2023;207:107116.
PubMed Abstract available

MACNEIL A, Li G, Jiang Y, de Groh M, et al
Incident and recurrent depression among older adults with asthma during the COVID-19 pandemic: Findings from the Canadian Longitudinal Study on Aging.
Respir Med. 2023 Jan 11:107003. doi: 10.1016/j.rmed.2022.107003.
PubMed Abstract available

LOSOL P, Sokolowska M, Chang YS
Interactions between microbiome and underlying mechanisms in asthma.
Respir Med. 2023 Jan 11:107118. doi: 10.1016/j.rmed.2023.107118.
PubMed Abstract available

LIU Y, Li P, Jiang T, Li Y, et al
Epidermal growth factor receptor in asthma: A promising therapeutic target?
Respir Med. 2023;207:107117.
PubMed Abstract available

RUAN H, Zhang H, Wang J, Zhao H, et al
Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Respir Med. 2023;206:107090.
PubMed Abstract available

FLORA S, Marques A, Hipolito N, Morais N, et al
Test-retest reliability, agreement and construct validity of the International Physical Activity Questionnaire short-form (IPAQ-sf) in people with COPD.
Respir Med. 2023;206:107087.
PubMed Abstract available

SOUTO-MIRANDA S, Rocha V, Mendes MA, Simao P, et al
The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation.
Respir Med. 2023;206:107086.
PubMed Abstract available

MYERS LC, Murray R, Donato B, Liu VX, et al
Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease.
Respir Med. 2023;206:107064.
PubMed Abstract available

HARTMAN JE, Herth FJF, Shah P, Pison C, et al
Computed tomographic airway morphology after targeted lung denervation treatment in COPD.
Respir Med. 2023;206:107059.
PubMed Abstract available

December 2022

MATTILA T, Vasankari T, Kauppi P, Mazur W, et al
Mortality of asthma, COPD, and asthma-COPD overlap during an 18-year follow up.
Respir Med. 2022 Dec 31:107112. doi: 10.1016/j.rmed.2022.107112.
PubMed Abstract available

THEODORO EE, Rocha DGD, Bertolino JR, Guinossi RM, et al
Evaluating the effect of antidepressants on the relationship between depression and asthma.
Respir Med. 2022;207:107099.
PubMed Abstract available

LOUIS G, Schleich F, Louis R, Guillaume M, et al
How respiratory symptoms impact asthma-related quality of life in mild asthmatics.
Respir Med. 2022;207:107098.
PubMed Abstract available

RENNER A, Marth K, Breyer-Kohansal R, Pohl W, et al
Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria.
Respir Med. 2022;207:107097.
PubMed Abstract available

LI J, Price KR, Weeda ER, Garner SS, et al
Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
Respir Med. 2022;207:107096.
PubMed

LAORDEN D, Dominguez-Ortega J, Carpio C, Barranco P, et al
Long COVID outcomes in an asthmatic cohort and its implications for asthma control.
Respir Med. 2022 Dec 16:107092. doi: 10.1016/j.rmed.2022.107092.
PubMed

GOUDARZI H, Kimura H, Kimura H, Makita H, et al
Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
Respir Med. 2022;206:107089.
PubMed Abstract available

ROTHE T, von Garnier C, Bridevaux PO, Charbonnier F, et al
The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
Respir Med. 2022;206:107067.
PubMed Abstract available

BARDSLEY S, Criner GJ, Halpin DMG, Han MK, et al
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
Respir Med. 2022;205:107040.
PubMed Abstract available

CAZZOLA M, Matera MG
Clinically important deterioration: a composite tool for managing patients with COPD.
Respir Med. 2022;205:107054.
PubMed Abstract available

STEPHENSON H, Roberts M, Klimkeit E, Smith T, et al
Uncovering undernutrition in chronic obstructive pulmonary disease: Beyond body mass index.
Respir Med. 2022;205:107026.
PubMed Abstract available

WU J, Zhao X, Xiao C, Xiong G, et al
The role of lung macrophages in chronic obstructive pulmonary disease.
Respir Med. 2022;205:107035.
PubMed Abstract available

November 2022

THELEN JC, van Zelst CM, van Brummelen SE, Rauh S, et al
Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study.
Respir Med. 2022;206:107058.
PubMed Abstract available

ROCHE N, Nadif R, Fabry-Vendrand C, Pillot L, et al
Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.
Respir Med. 2022;206:107057.
PubMed Abstract available

ALIBERTI S, Gramegna A, Zucchetti S, Simonetta E, et al
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy.
Respir Med. 2022;205:107056.
PubMed

PLEASANTS RA, Chan AH, Mosnaim G, Costello RW, et al
Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease.
Respir Med. 2022;205:107038.
PubMed Abstract available

SUNJAYA A, Poulos L, Reddel H, Jenkins C, et al
Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity.
Respir Med. 2022;203:106984.
PubMed Abstract available

KOSTER TD, Eberhardt R, Huebner RH, Valipour A, et al
A multicenter, prospective, single-arm clinical investigation of a modified staged treatment algorithm using the AeriSeal system - The STAGE trial.
Respir Med. 2022;203:106989.
PubMed Abstract available

GOGOU E, Hatzoglou C, Zarogiannis SG, Siachpazidou D, et al
Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
Respir Med. 2022;203:106988.
PubMed Abstract available

HOSKOTE SS
Corrected formula for rectangular area ratio (RAR), a parameter used to quantify airflow limitation on expiratory flow-volume curves.
Respir Med. 2022;204:107032.
PubMed Abstract available

MUKHERJEE P, Bhattacharya D, Esquinas AM, Mandal M, et al
HFNC can bring the children with bronchiolitis off the ventilator earlier: Fact or fiction?
Respir Med. 2022;204:107033.
PubMed

KAHNERT K, Jorres RA, Jobst B, Wielputz MO, et al
Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET.
Respir Med. 2022;204:107014.
PubMed Abstract available

SANSORES RH, Paulin-Prado P, Robles-Hernandez R, Montiel-Lopez F, et al
Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
Respir Med. 2022;204:107010.
PubMed Abstract available

MOCHIZUKI F, Tanabe N, Iijima H, Shimada T, et al
Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features.
Respir Med. 2022;204:107011.
PubMed Abstract available

October 2022

MAIO S, Murgia N, Tagliaferro S, Angino A, et al
The Italian severe/uncontrolled asthma registry (RItA): A 12-month clinical follow-up.
Respir Med. 2022;205:107030.
PubMed Abstract available

VAN DER PALEN J, Slade D, Rehal S, Verma M, et al
A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
Respir Med. 2022;205:107031.
PubMed Abstract available

RYAN D, Keighley A, Jackson T
Patient perspectives in asthma: Listening to and learning from a new paradigm in translational research.
Respir Med. 2022;205:107013.
PubMed

CHAN KC, Au CT, Wong E, Chook P, et al
Inferior endothelial function improved following optimisation of asthma control in children.
Respir Med. 2022;204:107024.
PubMed Abstract available

TOOBA R, Wu TD
Obesity and asthma: A focused review.
Respir Med. 2022;204:107012.
PubMed

CABALLERO-SEGURA FJ, Lopez-de-Andres A, Jimenez-Garcia R, de Miguel-Yanes JM, et al
Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020.
Respir Med. 2022;204:107009.
PubMed Abstract available

GHOSH S, Rihan M, Ahmed S, Pande AH, et al
Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective.
Respir Med. 2022;204:107007.
PubMed Abstract available

PATRICIA DE SOUZA MENDES L, Parreira VF, Spencer LM, Zafiropoulos B, et al
Glittre endurance test: A new test to assess the functional capacity of individuals with chronic obstructive pulmonary disease.
Respir Med. 2022;202:106983.
PubMed Abstract available

VITACCA M, Paneroni M, Spanevello A, Ceriana P, et al
Effectiveness of pulmonary rehabilitation in individuals with Chronic Obstructive Pulmonary Disease according to inhaled therapy: The Maugeri study.
Respir Med. 2022;202:106967.
PubMed Abstract available

HINES SE, Gaitens JM, Brown CH, Glick DR, et al
Self-reported respiratory outcomes associated with blast exposure in post 9/11 veterans.
Respir Med. 2022;202:106963.
PubMed Abstract available

September 2022

MANEECHOTESUWAN K, Singh D, Fritscher LG, Dursunoglu N, et al
Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis.
Respir Med. 2022;203:106993.
PubMed Abstract available

TRAN C, Singh GV, Haider E, Boylan C, et al
Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
Respir Med. 2022;202:106982.
PubMed Abstract available

ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
Respir Med. 2022;202:106949.
PubMed Abstract available

SUNJAYA AP, Sengupta A, Martin A, Di Tanna GL, et al
Efficacy of self-management mobile applications for patients with breathlessness: Systematic review and quality assessment of publicly available applications.
Respir Med. 2022;201:106947.
PubMed Abstract available

ODAJIU I, Covantsev S, Sivapalan P, Mathioudakis AG, et al
Peripheral neuropathy: A neglected cause of disability in COPD - A narrative review.
Respir Med. 2022;201:106952.
PubMed Abstract available

CHRISTENSEN VL, Rustoen T, Thoresen M, Holm AM, et al
Stability of distinct symptom experiences in patients with chronic obstructive pulmonary disease (COPD).
Respir Med. 2022;201:106944.
PubMed Abstract available

AMIN R, Maiya GA, Mohapatra AK, Acharya V, et al
Effect of a home-based pulmonary rehabilitation program on functional capacity and health-related quality of life in people with interstitial lung disease - A randomized controlled trial protocol.
Respir Med. 2022;201:106927.
PubMed Abstract available

CHOI J, Park E, Park H, Kang D, et al
Effect of high-flow nasal cannula on mechanical ventilator duration in bronchiolitis patients.
Respir Med. 2022;201:106946.
PubMed Abstract available

FINAMORE P, Lattanzi G, Pedone C, Poci S, et al
Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE.
Respir Med. 2022;201:106951.
PubMed Abstract available

DIERICK BJH, Been-Buck S, Klemmeier T, Hagedoorn P, et al
Digital spacer data driven COPD inhaler adherence education: The OUTERSPACE proof-of-concept study.
Respir Med. 2022;201:106940.
PubMed Abstract available

SOUTO-MIRANDA S, Vaes AW, Gloeckl R, Grongstad A, et al
International perspectives on outcome measurement in pulmonary rehabilitation of people with COPD: A qualitative study.
Respir Med. 2022;201:106936.
PubMed Abstract available

HAMAKAWA Y, Sato S, Tanabe N, Rhee CK, et al
Non-respiratory symptom dominance is associated with depression in patients with chronic obstructive pulmonary disease.
Respir Med. 2022;201:106895.
PubMed Abstract available

August 2022

DOLLIVER WR, Wang W, Nardelli P, Rahaghi FN, et al
Pulmonary arterial pruning is associated with CT-derived bronchiectasis progression in smokers.
Respir Med. 2022;202:106971.
PubMed Abstract available

BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
Respir Med. 2022;202:106938.
PubMed Abstract available

TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
Respir Med. 2022;201:106950.
PubMed Abstract available

CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
Respir Med. 2022;201:106948.
PubMed Abstract available

CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
Is asthma control more than just an absence of symptoms? An expert consensus statement.
Respir Med. 2022;202:106942.
PubMed Abstract available

SOUTO-MIRANDA S, Antao J, Rodrigues G, Mendes MA, et al
Cut-off of the one-minute sit-to-stand test to detect functional impairment in people with chronic obstructive pulmonary disease.
Respir Med. 2022;199:106892.
PubMed Abstract available

TRELA KC, Zajac P, Zhu M, Press VG, et al
Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
Respir Med. 2022;200:106930.
PubMed Abstract available

FRAZIER WD, DaVanzo JE, Dobson A, Heath S, et al
Early Initiation of non-invasive ventilation at home improves survival and reduces healthcare costs in COPD patients with chronic hypercapnic respiratory failure: A retrospective cohort study.
Respir Med. 2022;200:106920.
PubMed Abstract available

MALTAIS F, Vogelmeier CF, Kerwin EM, Bjermer LH, et al
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
Respir Med. 2022;200:106918.
PubMed Abstract available

July 2022

HINE C, Desai M, Davies J, Sapey E, et al
A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis.
Respir Med. 2022;201:106937.
PubMed Abstract available

ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
Respir Med. 2022;201:106934.
PubMed Abstract available

LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
Respir Med. 2022;201:106935.
PubMed Abstract available

HENRY SL, Moore LE, Brotto AR, Rowland S, et al
Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
Respir Med. 2022;200:106932.
PubMed Abstract available

ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
Respir Med. 2022;200:106917.
PubMed Abstract available

DALIN DA, Lokke A, Kristiansen P, Jensen C, et al
A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD.
Respir Med. 2022;198:106880.
PubMed Abstract available

YOHANNES AM, Murri MB, Hanania NA, Regan EA, et al
Depressive and anxiety symptoms in patients with COPD: A network analysis.
Respir Med. 2022;198:106865.
PubMed Abstract available

AL CHIKHANIE Y, Bailly S, Amroussa I, Veale D, et al
Clustering of COPD patients and their response to pulmonary rehabilitation.
Respir Med. 2022;198:106861.
PubMed Abstract available

ZAFARI Z, Lee TY, Sadatsafavi M
External validation of lung function predictions in real-world cohorts of COPD.
Respir Med. 2022;198:106859.
PubMed Abstract available

June 2022

PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
Respir Med. 2022;200:106916.
PubMed Abstract available

LIU L, Zhang X, Zhang L, Liu Y, et al
Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
Respir Med. 2022;200:106924.
PubMed Abstract available

HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
Respir Med. 2022;200:106921.
PubMed Abstract available

CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
Respir Med. 2022;200:106915.
PubMed Abstract available

LUOTO J, Pihlsgard M, Pistolesi M, Paoletti M, et al
Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population.
Respir Med. 2022;200:106899.
PubMed Abstract available

LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
Associations of asthma self-management and mental health in adolescents: A scoping review.
Respir Med. 2022;200:106897.
PubMed Abstract available

SINGH D, Rabe KF, Martinez FJ, Krull M, et al
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary d
Respir Med. 2022;197:106857.
PubMed Abstract available

BRUSSE-KEIZER M, Citgez E, Zuur-Telgen M, Kerstjens HAM, et al
Difference in survival between COPD patients with an impaired immune reaction versus an adequate immune reaction to seasonal influenza vaccination: The COMIC study.
Respir Med. 2022;197:106851.
PubMed Abstract available

SULKU J, Janson C, Melhus H, Stallberg B, et al
Changes in critical inhaler technique errors in inhaled COPD treatment - A one-year follow-up study in Sweden.
Respir Med. 2022;197:106849.
PubMed Abstract available

COLAK Y, Nordestgaard BG, Vestbo J, Afzal S, et al
Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study.
Respir Med. 2022;197:106852.
PubMed Abstract available

DA LUZ GOULART C, Oliveira MR, Sendin FA, Mendes RG, et al
Prognostic value of key variables from cardiopulmonary exercise testing in patients with COPD: 42-month follow-up.
Respir Med. 2022;197:106856.
PubMed Abstract available

MANNINO D, Bogart M, Wu B, Germain G, et al
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
Respir Med. 2022;197:106807.
PubMed Abstract available

YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety.
Respir Med. 2022;197:106850.
PubMed Abstract available

May 2022

SON JH, Park JS, Lee JU, Kim MK, et al
A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
PubMed Abstract available

IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
PubMed Abstract available

JIAO T, Schnitzer ME, Forget A, Blais L, et al
Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
Respir Med. 2022;198:106866.
PubMed Abstract available

GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
Respir Med. 2022;200:106863.
PubMed Abstract available

SIRAJ RA, McKeever TM, Gibson JE, Bolton CE, et al
Incidence of depression and antidepressant prescription in patients with COPD: A large UK population-based cohort study.
Respir Med. 2022;196:106804.
PubMed Abstract available

HARTMAN JE, Welling JBA, Klooster K, Carpaij OA, et al
Survival in COPD patients treated with bronchoscopic lung volume reduction.
Respir Med. 2022;196:106825.
PubMed Abstract available

HESSE K, Bourke S, Steer J
Heart failure in patients with COPD exacerbations: Looking below the tip of the iceberg.
Respir Med. 2022;196:106800.
PubMed Abstract available

April 2022

CHIU YC, Chang WP, Tang GJ, Lan TY, et al
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders.
Respir Med. 2022;197:106833.
PubMed Abstract available

OBLING N, Backer V, Hurst JR, Bodtger U, et al
Nasal and systemic inflammation in Chronic Obstructive Pulmonary Disease (COPD).
Respir Med. 2022;195:106774.
PubMed Abstract available

MACDONALD DM, Palzer EF, Abbasi A, Baldomero AK, et al
Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.
Respir Med. 2022;194:106775.
PubMed Abstract available

March 2022

KORN S, Milger K, Skowasch D, Timmermann H, et al
Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
Respir Med. 2022;196:106827.
PubMed

RILEY L, Lascano J
Labelling Alpha-1 antitrypsin deficiency in the medical record - A call to action.
Respir Med. 2022;193:106749.
PubMed Abstract available

YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease.
Respir Med. 2022;193:106742.
PubMed Abstract available

PHILLIPS TM, Moloney C, Sneath E, Beccaria G, et al
Associated factors, assessment, management, and outcomes of patients who present to the emergency department for acute exacerbation of chronic obstructive pulmonary disease: A scoping review.
Respir Med. 2022;193:106747.
PubMed Abstract available

February 2022

KORN S, Milger K, Skowasch D, Timmermann H, et al
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
Respir Med. 2022;195:106793.
PubMed Abstract available

BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
PubMed Abstract available

AL-AHMAD M, Webb D
A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
Respir Med. 2022;194:106771.
PubMed Abstract available

ABOZID H, Baxter CA, Hartl S, Braun E, et al
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria.
Respir Med. 2022;192:106726.
PubMed Abstract available

MAROTT JL, Colak Y, Ingebrigtsen TS, Vestbo J, et al
Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population.
Respir Med. 2022;192:106725.
PubMed Abstract available

January 2022

JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
Mental health in patients with asthma: A population-based case-control study.
Respir Med. 2022;193:106758.
PubMed Abstract available

VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
Respir Med. 2022;193:106757.
PubMed Abstract available

METERSKY ML, Choate R, Aksamit TR, Conrad D, et al
Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry.
Respir Med. 2022;193:106746.
PubMed Abstract available

TAKASAKA N, Hosaka Y, Fukuda T, Shinfuku K, et al
Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
Respir Med. 2022;192:106738.
PubMed Abstract available

ELBORN JS, Blasi F, Haworth CS, Ballmann M, et al
Bronchiectasis and inhaled tobramycin: A literature review.
Respir Med. 2022;192:106728.
PubMed Abstract available

BOURDIN A, Molinari N
Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
Respir Med. 2022;191:105999.
PubMed

BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
Respir Med. 2022;191:106088.
PubMed

MARTIN N, Papi A, Bratton DJ, Chan R, et al
Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
Respir Med. 2022;191:106065.
PubMed

BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
Respir Med. 2022;191:105991.
PubMed Abstract available

SHEIKH D, Tripathi N, Chandler TR, Furmanek S, et al
Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
Respir Med. 2022;191:106714.
PubMed Abstract available

BERGHAUS TM, Karschnia P, Haberl S, Schwaiblmair M, et al
Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic.
Respir Med. 2022;191:106120.
PubMed

MIR T, Uddin M, Khalil A, Lohia P, et al
Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population.
Respir Med. 2022;191:106720.
PubMed Abstract available

OBLING N, Rangelov B, Backer V, Hurst JR, et al
Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD.
Respir Med. 2022;191:106710.
PubMed Abstract available

JALASTO J, Lassmann-Klee P, Schyllert C, Luukkonen R, et al
Occupation, socioeconomic status and chronic obstructive respiratory diseases - The EpiLung study in Finland, Estonia and Sweden.
Respir Med. 2022;191:106403.
PubMed Abstract available

OBI ON, Judson MA, Birring SS, Maier LA, et al
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI).
Respir Med. 2022;191:106436.
PubMed Abstract available

BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
Respir Med. 2022;191:106106.
PubMed

December 2021

TERPSTRA LC, Altenburg J, Mohamed Hoesein FA, Bronsveld I, et al
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial.
Respir Med. 2021;192:106718.
PubMed Abstract available

MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
Respir Med. 2021;191:106724.
PubMed Abstract available

WILGUS ML, Abtin F, Markovic D, Tashkin DP, et al
Panlobular emphysema is associated with COPD disease severity: A study of emphysema subtype by computed tomography.
Respir Med. 2021;192:106717.
PubMed Abstract available

BARTOLI ML, Latorre M, Vagaggini B, Nieri D, et al
Are sputum eosinophils associated with a different phenotype in COPD patients? A retrospective study.
Respir Med. 2021;190:106672.
PubMed Abstract available

PENG J, Wu F, Tian H, Yang H, et al
Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
Respir Med. 2021;190:106681.
PubMed Abstract available

MONGIARDO MA, Robinson SA, Finer EB, Cruz Rivera PN, et al
The Effect of a web-based physical activity intervention on COPD knowledge: A secondary cohort study.
Respir Med. 2021;190:106677.
PubMed Abstract available

LEE CT, Chien JY, Hsu MJ, Wu HD, et al
Inspiratory muscle activation during inspiratory muscle training in patients with COPD.
Respir Med. 2021;190:106676.
PubMed Abstract available

YAMAMOTO A, Nakamoto H, Yamaguchi T, Sakai H, et al
Validity of a novel respiratory rate monitor comprising stretchable strain sensors during a 6-min walking test in patients with chronic pulmonary obstructive disease.
Respir Med. 2021;190:106675.
PubMed Abstract available

CAILLE P, Alexandre F, Molinier V, Heraud N, et al
The role of personality traits in inpatient pulmonary rehabilitation response in patients with chronic obstructive pulmonary disease.
Respir Med. 2021;190:106680.
PubMed Abstract available

AL CHIKHANIE Y, Bailly S, Amroussia I, Veale D, et al
Trajectories of COPD patients' response to repeated pulmonary rehabilitation programs.
Respir Med. 2021;190:106678.
PubMed Abstract available

IRINA BP, Steluta MM, Emanuela T, Diana M, et al
Respiratory muscle training program supplemented by a cell-phone application in COPD patients with severe airflow limitation.
Respir Med. 2021;190:106679.
PubMed Abstract available

November 2021

FAN Q, Ong ASE, Koh MS, Doshi K, et al
The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
Respir Med. 2021;190:106673.
PubMed Abstract available

JEONG JS, Kim JS, You YS, Yeom SW, et al
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease.
Respir Med. 2021;189:106640.
PubMed Abstract available

SUISSA S, Dell'Aniello S, Ernst P
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety.
Respir Med. 2021;189:106645.
PubMed Abstract available

PALM A, Ekstrom M
Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy - The population-based DISCOVERY study.
Respir Med. 2021;189:106659.
PubMed Abstract available

DE BISSCHOP C, Caron F, Ingrand P, Bretonneau Q, et al
Does branched-chain amino acid supplementation improve pulmonary rehabilitation effect in COPD?
Respir Med. 2021;189:106642.
PubMed Abstract available

KARIM A, Muhammad T, Ustrana S, Qaisar R, et al
Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease.
Respir Med. 2021;189:106662.
PubMed Abstract available

OIE MR, Sue-Chu M, Helvik AS, Steinsvag SK, et al
Rhinosinusitis without nasal polyps is associated with poorer health-related quality of life in COPD.
Respir Med. 2021;189:106661.
PubMed Abstract available

KUNUTSOR SK, Jae SY, Makikallio TH, Kurl S, et al
High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study.
Respir Med. 2021;189:106647.
PubMed Abstract available

AL-MOAMARY MS, Kokturk N, Idrees MM, Sen E, et al
Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus.
Respir Med. 2021;189:106641.
PubMed Abstract available

IWAKURA M, Wakasa M, Okura K, Kawagoshi A, et al
Functionally relevant threshold of inspiratory muscle strength in patients with chronic obstructive pulmonary disease.
Respir Med. 2021;188:106625.
PubMed Abstract available

AGGARWAL R, Lam AC, Huang J, Hueniken K, et al
Stratification and management of patients ineligible for lung cancer screening.
Respir Med. 2021;188:106610.
PubMed Abstract available

ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
Respir Med. 2021;188:106621.
PubMed Abstract available

HARTMAN JE, Conway F, Degano B, Augustijn SWS, et al
Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD.
Respir Med. 2021;188:106604.
PubMed

KEMP R, Pustulka I, Boerner G, Smela B, et al
Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome-a systematic literature review.
Respir Med. 2021;188:106608.
PubMed Abstract available

October 2021

CZIRA A, Turner M, Martin A, Hinds D, et al
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
Respir Med. 2021;191:106670.
PubMed Abstract available

ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
Respir Med. 2021;189:106639.
PubMed Abstract available

CHEN J, Weldemichael L, Zeng S, Giang B, et al
Actigraphy informs distinct patient-centered outcomes in Pre-COPD.
Respir Med. 2021;187:106543.
PubMed Abstract available

RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
Respir Med. 2021;187:106595.
PubMed Abstract available

AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
Respir Med. 2021;187:106572.
PubMed Abstract available

HOSKING L, Yeo A, Hoffman J, Chiano M, et al
Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation.
Respir Med. 2021;187:106573.
PubMed Abstract available

WAN ES, Goldstein RL, Garshick E, DeMeo DL, et al
Molecular markers of aging, exercise capacity, & physical activity in COPD.
Respir Med. 2021;187:106576.
PubMed Abstract available

RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
Risk factors for irreversible airway obstruction after infant bronchiolitis.
Respir Med. 2021;187:106545.
PubMed Abstract available

September 2021

KAPUR N, Stroil-Salama E, Morgan L, Yerkovich S, et al
Factors associated with "Frequent Exacerbator" phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry.
Respir Med. 2021;188:106627.
PubMed Abstract available

OLIVEIRA A, Quach S, Alsubheen S, Dasouki S, et al
Rapid access rehabilitation after exacerbations of COPD - A qualitative study.
Respir Med. 2021;186:106532.
PubMed Abstract available

LEO F, Bannehr M, Valenta S, Lippeck M, et al
Impact of a computerized physician order entry (CPOE)-based antibiotic stewardship intervention on the treatment duration for pneumonia and COPD exacerbations.
Respir Med. 2021;186:106546.
PubMed Abstract available

GAZOURIAN L, Regis SM, Pagura EJ, Price LL, et al
Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort.
Respir Med. 2021;186:106540.
PubMed Abstract available

NIKOLAOU V, Massaro S, Garn W, Fakhimi M, et al
The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities.
Respir Med. 2021;186:106528.
PubMed Abstract available

CAMAC ER, Voelker H, Criner GJ
Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
Respir Med. 2021;186:106526.
PubMed Abstract available

LINDBERG A, Lindberg L, Sawalha S, Nilsson U, et al
Large underreporting of COPD as cause of death-results from a population-based cohort study.
Respir Med. 2021;186:106518.
PubMed Abstract available

August 2021

VITACCA M, Ambrosino N, Belli S, Vigna M, et al
The severity of acute exacerbations of COPD and the effectiveness of pulmonary rehabilitation.
Respir Med. 2021;184:106465.
PubMed Abstract available

GILLIAM EA, Kilgore KL, Liu Y, Bernier L, et al
Managing the experience of breathlessness with Tai Chi: A qualitative analysis from a randomized controlled trial in COPD.
Respir Med. 2021;184:106463.
PubMed Abstract available

GUO C, Yu T, Chang LY, Bo Y, et al
Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort study.
Respir Med. 2021;184:106471.
PubMed Abstract available

METERAN H, Thomsen SF, Miller MR, Hjelmborg J, et al
Impact of the spirometric definition on comorbidities in chronic obstructive pulmonary disease.
Respir Med. 2021;184:106399.
PubMed Abstract available

TAKEI N, Suzuki M, Tanabe N, Oguma A, et al
Combined assessment of pulmonary arterial enlargement and coronary calcification predicts the prognosis of patients with chronic obstructive pulmonary disease.
Respir Med. 2021;185:106520.
PubMed Abstract available

CASTELLO-SIMOES V, Kabbach EZ, Schafauser NS, Camargo PF, et al
Brain-heart autonomic axis across different clinical status and severity of chronic obstructive pulmonary disease.
Respir Med. 2021;185:106511.
PubMed Abstract available

CORLATEANU A, Plahotniuc A, Corlateanu O, Botnaru V, et al
Multidimensional indices in the assessment of chronic obstructive pulmonary disease.
Respir Med. 2021;185:106519.
PubMed Abstract available

MARTINEZ FJ, Rabe KF, Ferguson GT, Wedzicha JA, et al
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Respir Med. 2021;185:106509.
PubMed Abstract available

KELLERER C, Kahnert K, Trudzinski FC, Lutter J, et al
COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort.
Respir Med. 2021;185:106461.
PubMed Abstract available

PATHAK JL, Yan Y, Zhang Q, Wang L, et al
The role of oral microbiome in respiratory health and diseases.
Respir Med. 2021;185:106475.
PubMed Abstract available

ANDRIANOPOULOS V, Gloeckl R, Schneeberger T, Jarosch I, et al
Benefits of pulmonary rehabilitation in COPD patients with mild cognitive impairment - A pilot study.
Respir Med. 2021;185:106478.
PubMed Abstract available

June 2021

SHE W, Jia S, Hua Y, Feng X, et al
The effect of nitrogen dioxide and atmospheric pressure on hospitalization risk for chronic obstructive pulmonary disease in Guangzhou, China.
Respir Med. 2021;182:106424.
PubMed Abstract available

CANTOR JO, Ma S, Liu X, Campos MA, et al
A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
Respir Med. 2021;182:106402.
PubMed Abstract available

MARTH K, Renner A, Pohl W
TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD.
Respir Med. 2021;182:106398.
PubMed Abstract available

KRAEN M, Frantz S, Nihlen U, Engstrom G, et al
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity.
Respir Med. 2021;182:106404.
PubMed Abstract available

KIM C, Ko Y, Lee JS, Rhee CK, et al
Predicting long-term mortality with two different criteria of exercise-induced desaturation in COPD.
Respir Med. 2021;182:106393.
PubMed Abstract available

AMADO CA, Munoz P, Garcia-Unzueta M, Aguero J, et al
High parathyroid hormone predicts exacerbations in COPD patients with hypovitaminosis D.
Respir Med. 2021;182:106416.
PubMed Abstract available

AL-QEREM WA, Jarab AS
Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
Respir Med. 2021;182:106397.
PubMed Abstract available

May 2021

PUDDU PE, Menotti A, Kromhout D, Kafatos A, et al
Chronic bronchitis in the 50-year follow-up of the European cohorts of the Seven Countries Study: prevalence, mortality and association with cardiovascular diseases.
Respir Med. 2021;181:106385.
PubMed Abstract available

VINCKEN S, Sylvia V, Daniel S, Thomas E, et al
The role of FeNO in stable COPD patients with eosinophilic airway inflammation.
Respir Med. 2021;181:106377.
PubMed

CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
Sedentary time in people with obstructive airway diseases.
Respir Med. 2021;181:106367.
PubMed Abstract available

HEUBEL AD, Kabbach EZ, Schafauser NS, Phillips SA, et al
Noninvasive ventilation acutely improves endothelial function in exacerbated COPD patients.
Respir Med. 2021;181:106389.
PubMed Abstract available

April 2021

PINI L, Giordani J, Gardini G, Concoreggi C, et al
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy.
Respir Med. 2021;179:106334.
PubMed Abstract available

YANGUI F, Touil A, Antit S, Zakhama L, et al
COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.
Respir Med. 2021;179:106335.
PubMed Abstract available

VERBERKT CA, van den Beuken-van Everdingen MHJ, Dirksen CD, Schols JMGA, et al
Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
Respir Med. 2021;179:106330.
PubMed Abstract available

TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
Comparative analysis between available challenge tests in the hyperventilation syndrome.
Respir Med. 2021;179:106329.
PubMed Abstract available

ARMSTRONG M, Hume E, McNeillie L, Chambers F, et al
Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients' experiences of physical activity.
Respir Med. 2021;180:106353.
PubMed Abstract available

LAMMI MR, Ghonim MA, Johnson J, D'Aquin J, et al
Acute effect of inhaled iloprost on exercise dynamic hyperinflation in COPD patients: A randomized crossover study.
Respir Med. 2021;180:106354.
PubMed Abstract available

March 2021

TURAN PA, Turan O, Guldaval F, Anar C, et al
Transitions between COPD groups: A cross-sectional study in Turkey.
Respir Med. 2021;178:106310.
PubMed Abstract available

January 2021

ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
Respir Med. 2021;176:106281.
PubMed Abstract available

OLIVEIRA CC, Annoni R, Lee AL, McGinley J, et al
Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review.
Respir Med. 2021;176:106284.
PubMed Abstract available

LOPEZ-PINTOR E, Grau J, Gonzalez I, Bernal-Soriano MC, et al
Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies.
Respir Med. 2021;176:106280.
PubMed Abstract available

BAHA A, Kokturk N
Physician's attitude against COPD guidelines and the choice of first-line treatment for COPD.
Respir Med. 2021;176:106273.
PubMed Abstract available

BJERRUM AS, Skjold T, Schmid JM
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
Respir Med. 2021;176:106260.
PubMed Abstract available

FRANCE G, Orme MW, Greening NJ, Steiner MC, et al
Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD.
Respir Med. 2021;176:106249.
PubMed Abstract available

KEOGH E, Mark Williams E
Managing malnutrition in COPD: A review.
Respir Med. 2021;176:106248.
PubMed Abstract available

ZAIGHAM S, Dencker M, Karlsson MK, Thorsson O, et al
Lung function is associated with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in school-aged children.
Respir Med. 2021;176:106235.
PubMed Abstract available

KOHLBRENNER D, Clarenbach CF, Thiel S, Roeder M, et al
A few more steps lead to improvements in endothelial function in severe and very severe COPD.
Respir Med. 2021;176:106246.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.